Naschitz Brandes Amir advised DayTwo.
DayTwo closed a $37 million financing round to continue development of technologies and solutions designed to improve the health of people with diabetes and other metabolic diseases.
DayTwo is a leading Israeli precision medicine company.
The Naschitz Brandes Amir team included partners Noga Devecseri Spira (Picture), Assif Rosenberg and associate Noa Nitzan.
Law Firms: Naschitz Brandes Amir;
Clients: DayTwo ;